ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag infectious disease hiv history

DNA molecule.
Finding DNA Tags in AAV Stacks
Mariella Bodemeier Loayza Careaga, PhD | Mar 7, 2024 | 8 min read
Ten years ago, scientists put DNA barcodes in AAV vectors, creating an approach that simplified, expedited, and streamlined AAV screening. 
Infectious Disease
The Scientist Staff | Nov 23, 1997 | 3 min read
Edited by: Steve Bunk J.L. Eron, S.L. Benoit, J. Jemsek, R.D. MacArthur, J. Santana, J.B. Quinn, D.R. Kuritzkes, M.A. Fallon, M. Rubin, "Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter," New England Journal of Medicine, 333:1662-9, 1995. (Cited in 120 publications through October 1997) Comments by Joseph Jemsek, Nalle Clinic, Charlotte, N.C. Among viruses that cause infectious disease, HIV is particularly adept at mutating
An Eclectic Look at Infectious Diseases
Ricki Lewis | Aug 20, 2000 | 7 min read
Graphic: Cathleen Heard A week after the controversial XIII International AIDS Conference in Durban, South Africa, a much smaller gathering in Atlanta took a broader view of the current emergence and reemergence of many infectious diseases. The International Conference on Emerging Infectious Diseases 2000, held July 16-19, attracted more than 2,000 attendees representing 35 nations. The Centers for Disease Control and Prevention (CDC), the American Society for Microbiology, the Council of State
Mapping Disease
Ed Yong | Apr 28, 2013 | 4 min read
Online tools could help to improve our patchy knowledge of the whereabouts of infectious diseases.
Human blood in a plastic Intravenous drip bag, the tube running out of the image. Square crop. Horizontal with copy space.
Opinion: What the History of Blood Transfusion Reveals About Risk
Paul A. Offit | Sep 1, 2021 | 5 min read
Every medical intervention—even one with a centuries-long history—brings dangers, some of which become clear only later.
HIV
Steve Bunk | Dec 5, 1999 | 5 min read
J.K. Wong, M. Hezareh, H.F. Gunthard, D.V. Havlir, C.C. Ignacio, C.A. Spina, D.D. Richman, "Recovery of replication-competent HIV despite prolonged suppression of plasma viremia," Science, 278:1291-5, 1997. (Cited in more than 215 papers since publication) Comments by Douglas D. Richman, professor of pathology and medicine, University of California, San Diego, and San Diego VA Healthcare System D. Finzi, M. Hermankova, T. Pierson, L.M. Carruth, C. Buck, R.E. Chaisson, T.C. Quinn, K. Chadwick, J.
Science crime: A recent history
Jef Akst | Feb 15, 2010 | 3 min read
Last Friday, biology professor Amy Bishop shocked the country when she linkurl:allegedly shot and killed;http://www.nytimes.com/2010/02/13/us/13alabama.html?emc=eta1 three of her colleagues at the University of Alabama in Huntsville, purportedly motivated by the university's recent decision to deny her tenure. Although certainly one of the most heinous crimes in recent memory, it is by no means the first criminal offense to disturb the scientific community. Here is a timeline of some disquieting
Mounting Threat Of Infectious Diseases Contributes To Rising Need For Immunology Research Specialists
Marcia Clemmitt | Mar 21, 1993 | 10 min read
In today's otherwise sluggish biomedical job market, career prospects for these scientists are improving in academia as well as industry Immunology research is riding the crest of a wave, with significant laboratory results proliferating, observers of the field say. "Immunology remains one area in biomedicine that has relatively good prospectives for employment, and one that is likely to continue doing somewhat better than most others," says Robert Rich, a professor of microbiology, immuno
HIV virus
HIV-1 Genome Extracted from 1966 Tissue Sample
Nicoletta Lanese | Aug 19, 2019 | 2 min read
Scientists spent five years reconstructing what is now the oldest HIV-1 genome yet recovered.
The Dangers of Expanding HIV's Host Range
Alexander Kohn | Nov 29, 1987 | 3 min read
Scientists attending the Asilomar conference at Pacific Grove, Calif., in February 1975, made history by expressing public concern about the then newly recognized opportunities for splicing DNA artificially from one organism to another. Some possibilities—such as the introduction into the ubiquitous Escherichia coli of genes coding for botulinum toxin—were seen as so risky that they would never even be attempted. But many other fears ventilated at that time have proved to be un-fou

Run a Search

ADVERTISEMENT